Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
Last edited:
I still don't have the impression that that view is particularly common amongst virologists (or that it's increasing in popularity). Rather, they still think the theory is hard to disprove but unlikely: it's much more likely to be a natural crossover (somewhere) which somehow emerged at the Wuhan market. (Actually two crossover events.) If anything, I think the lab-leak idea is rather less popular amongst experts since https://www.science.org/doi/10.1126/science.abp8715If it was (which is looking likely), a lab made/messed about with "thing", if they had promptly admitted this (assuming it was an accident and not deliberate), perhaps a global spread of this "thing" could have been avoided, if it was contained fully in Wuhan.
Also to the hundreds of thousands of healthcare professionals worldwide who're very familiar with flu and its common effects and who've been very clear that what they saw in early 2020 was different.It would be in exceedingly bad taste, and incredibly disrespectful to the tens or thousands of people who have died as a result of infection with sars-cov2 to have it described by anyone as “the so called virus”.
Changes in immunity (through vaccination or infection) surely change the virus. A new variant has to do well in a population that's mostly been vaccinated and almost all have had exposure to a few variants. The surviving population is quite different to the population in early 2020.How have the "jabs" changed the virus? have the jabs created varriants (making things worse in the longer term)?
Vaccinating in the middle of a pandemic, surely is like, shutting the stable door after the horse has left?
Everyone's always agreed that the sooner you get a vaccine the better. The expectation early on was that it would take years (though apparently the teams working on the vaccines were pretty confident they'd have candidates much sooner, and just didn't know how effective they'd be). That's one of the arguments in favour of drastic restrictions like NZ: it allows more time for vaccines and other treatments to be developed.I agree with what you are saying, I am just uncertain about how effective it can be to vaccinate when the pandemic is already in full swing. Usually, like for example with the flu viruses, we try to get ahead and predict the strains before they become wide spread. Though I do understand the reason why.
I suspect if I did see that research I just wouldn't understand it. Virologists, infectious disease doctors, and everyone else in the field seems content that they're able to identify the virus (and sequence variants).I'd like to see what research our and other countries have done into purifying and isolating the sarscov2 virus.
The vaccines were developed from a kind-of leaked sequence from China. And initially the thought (in Oxford) was to use it as a practice run in developing a vaccine quickly using the platform they'd developed.from the people working day in and day out in vaccine development, it's not some conspiracy theory or nonsense.
The difference is that I don't see it as a problem. It gave the scientists a bit of a head start: rather than waiting for the sick and dead people to appear in the UK, they were able to start on a vaccine with just a sequence. (Similarly in other countries, of course.)Thanks @Bruce Stephens that's pretty much what I said.
They did, yes. The Oxford team had been working on exactly that: a platform that would allow quick development of a vaccine for new viruses. And they'd developed candidates for SARS1 and MERS (which I think didn't go anywhere for the usual reason: lack of funding). mRNA vaccines were also intended for this: just add the antigen sequence you want in the right place and you've got a vaccine.Of course, having the sequence would only be a head start if you already had the technology to develop it into a vaccine? I take it then that they all had this technology?
Money, mostly. The first vaccines were unexpectedly good and so it's much harder to get money to develop others. Having said that, there are lots of other vaccines of various kinds. WHO publishes a spreadsheet: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines There's still an obvious need for cheaper and more convenient vaccines for poorer countries.Alternatively, what was stopping them from going down the traditional route or at least some of them going down that route to try any maximise the efficacy data once the vaccines were rolled out?
"this measure" being levels of neutralising antibodies.So.. in that data, it made reference to an inactivated vaccine called Valneva (traditional type vaccine), made in Edinburgh which got approval from the MHRA. I'd honestly never herd about this one. There is a link here in the BBC. It says it this:
"It outperformed the AstraZeneca vaccine on this measure in head-to-head tests."
I presume it's a combination of time (they wanted to start as soon as they could) and they felt no reason to delay. Working from the sequence from China they were able to start in late January. I don't know when we had the first sequences from the UK, but it was probably around March.Bruce, any ideas why each country/manufacturer chose not to sequence the virus independently for themselves rather than downloading it from China?